NCT00149708View on ClinicalTrials.gov

Consequence of Lifetime Isolated Growth Hormone Deficiency

NACompletedINTERVENTIONAL

Enrollment

400

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

Growth Hormone Deficiency

Interventions

DRUG

growth hormone administration for 6 months

depot GH (Nutropin depot) 13.4 mg every 14 days

Trial Locations (1)

49060

Federal University of Sergipe, Aracaju

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH